ArticleSurgical endoscopy2023
Lumen-apposing metal stents for the treatment of benign gastrointestinal tract strictures: a single-center experience and proposed treatment algorithm.
Article in Surgical endoscopy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 18 citations in OpenAlex.
- Removal of a Decade-Long Indwelling Lumen-Apposing Metal Stent for Post-Roux-en-Y Gastric Bypass Gastrojejunostomy Stricture.ACG case reports journal · 2026Article
- Concurrent stricturoplasty with lumen-apposing metal stents for gastrojejunal strictures after Roux-en-Y gastric bypass.Surgical endoscopy · 2026Article
- Role of Endoscopic Ultrasound-guided Gastroenterostomy for Benign Gastric Outlet Obstruction.DEN open · 2026Review
- Esophageal strictures: Management beyond dilation.World journal of gastrointestinal endoscopy · 2025Review
- Tack-only fixation of lumen-apposing metal stents: leave the suture at home.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2025Article
- Lumen Apposing Metal Stents for Gastrojejunal Anastomotic Stricture Following Metabolic Bariatric Surgery.Obesity surgery · 2025Article
- Article
- Safety and Efficacy of Lumen-Apposing Metal Stents for Management of Late Refractory Gastro-jejunal Strictures in Patients with Roux-en-Y Gastric Bypass (with Video).Digestive diseases and sciences · 2025Article
- The Trajectory of Revisional Bariatric Surgery: Open to Laparoscopic to Robotic.Journal of clinical medicine · 2024Review
- A Successful 12-Month Trial of a Lumen-Apposing Self-Expandable Metallic Stent on a Benign Recalcitrant After Surgical Stricture.ACG case reports journal · 2024Article
- Marginal Ulcers after Roux-en-Y Gastric Bypass: Etiology, Diagnosis, and Management.Journal of clinical medicine · 2023Review
- Reduction of Lams-Related Adverse Events with Accumulating Experience in a Large-Volume Tertiary Referral Center.Journal of clinical medicine · 2023Article
- Clinical application and follow-up of electrocautery-enhanced lumen-apposing metal stents for endoscopic ultrasonography-guided interventions.Annals of medicine · 2023Review
- Efficacy of lumen-apposing metal stents for the management of benign gastrointestinal stricture: a systematic review and meta-analysis.Annals of gastroenterologyArticle
- Benign gastric outlet obstruction: evolving strategies from surgery to endoscopic ultrasound-guided gastrojejunostomy.Therapeutic advances in gastrointestinal endoscopyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLumen-apposing metal stents (LAMS) are an alternative therapeutic option for benign gastrointestinal (GI) tract strictures. Our study aimed to evaluate the safety and efficacy of LAMS for the management of benign GI strictures.
methodsConsecutive patients who underwent a LAMS placement for benign luminal GI strictures at a tertiary care center between January 2014 and July 2021 were reviewed. Primary outcomes included technical success, early clinical success, and adverse events (AEs). Other outcomes included rates of stent migration and re-intervention after LAMS removal.
resultsOne hundred and nine patients who underwent 128 LAMS placements (67.9% female, mean age of 54.3 ± 14.2 years) were included, and 70.6% of the patients had failed prior endoscopic treatments. The majority of strictures (83.5%) were anastomotic, and the most common stricture site was the gastrojejunal anastomosis (65.9%). Technical success was achieved in 100% of procedures, while early clinical success was achieved in 98.4%. The overall stent-related AE rate was 25%. The migration rate was 27.3% (35/128). Of these, five stents were successfully repositioned endoscopically. The median stent dwell time was 119 days [interquartile range (IQR) 68-189 days], and the median follow-up duration was 668.5 days [IQR: 285.5-1441.5 days]. The re-intervention rate after LAMS removal was 58.3%.
conclusionsLAMS is an effective therapeutic option for benign GI strictures, offering high technical and early clinical success. However, the re-intervention rate after LAMS removal was high. In select cases, using LAMS placement as destination therapy with close surveillance is a reasonable option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.